Search
CLC bio Signs Strategic Collaborative Agreement with J. Craig Venter Institute
Cambridge, Massachusetts, USA — October 7, 2008 — CLC bio, a world leading full-service bioinformatics solution provider announced today an agreement with the J. Craig Venter Institute, a not-for profit genomic-focused research institute. The accord consists of a multi-year site license for the entire CLC bio bioinformatics suite of products. The goal is to implement CLC bio's enterprise solution as a scientific platform across all JCVI sites. This enterprise solution will provide...
J. Craig Venter Institute Launches New Genomics Education Program in California
LA JOLLA, CA — July 31, 2008 — The J. Craig Venter Institute (JCVI) announced today the launch of their genomics education program in California. This comprehensive Genomics Course for Educators, to be held at JCVI's La Jolla, California facility on July 29 through August 1, 2008, is designed for San Diego area teachers who want to become knowledgeable about the rapidly evolving field of genomics. JCVI received a private donation to provide stipends to each of the participating teachers,...
J. Craig Venter Institute Names Robert Friedman, Ph.D., Deputy Director of West Coast Facility
ROCKVILLE, MD and LA JOLLA, CA — June 26, 2008 — The J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, today announced that Robert Friedman, Ph.D., has been named the new Deputy Director of the JCVI La Jolla, California facility. The organization also announced the promotion of several key science leaders — Karen Nelson, Ph.D., Samuel Levy, Ph.D., and Yu-Hui Rogers, in the Rockville, Maryland headquarters. In his new role, Dr. Friedman...
Venter Institute Scientists Create First Synthetic Bacterial Genome
ROCKVILLE, MD — January 24, 2008 — A team of 17 researchers at the J. Craig Venter Institute (JCVI) has created the largest man-made DNA structure by synthesizing and assembling the 582,970 base pair genome of a bacterium, Mycoplasma genitalium JCVI-1.0. This work, published online today in the journal Science by Dan Gibson, Ph.D., et al, is the second of three key steps toward the team's goal of creating a fully synthetic organism. In the next step, which is...
TIGR / HGS Funding Relationship Reaches Early Conclusion
June 24, 1997 ROCKVILLE, MD-- June 24, 1997 -- The Institute for Genomic Research (TIGR) and Human Genome Sciences, Inc. (HGS) (NASDAQ: HGSI) today announced that they have signed an agreement whereby HGS will cease future payments to TIGR in return for relinquishing rights to future work done by TIGR. While this ends the TIGR/HGS relationship, HGS will retain all rights to patents granted now or in the future on work by TIGR prior to this agreement. Additionally, TIGR agrees not to enter...
TIGR Director J. Craig Venter, in the Sorcerer, undertakes sailing across the Atlantic along the same path as Columbus' Second Voyage
TIGR Director J. Craig Venter, in the Sorcerer, undertakes sailing across the Atlantic along the same path as Columbus' Second Voyage
Perkin-Elmer, Dr. Craig Venter, and TIGR Announce Formation of New Genomics Company
May 9, 1998 NORWALK, CT and ROCKVILLE, MD, May 9, 1998 -- The Perkin-Elmer Corporation (NYSE:PKN), Dr. J. Craig Venter, and The Institute for Genomic Research (TIGR) announced today that they have signed letters of intent relating to the formation by Perkin-Elmer and Dr. Venter of a new genomics company. Its strategy will be centered on a plan to substantially complete the sequencing of the human genome in three years. The new company's goal is to become the definitive source of genomic...
Claire Fraser, Ph.D. is named new TIGR President
September 21, 1998 ROCKVILLE, MD -- September 21, 1998 -- The Institute for Genomic Research (TIGR), the Nation's leading microbial genomics institution, announced today the appointment of Claire M. Fraser, Ph.D., as TIGR's new President. Dr. Fraser is replacing TIGR's founder, J. Craig Venter, who is now President of Celera Genomics Corporation. Her appointment is effective immediately. Dr. Venter served as TIGR's President and Chairman of the Board of Trustees for the last 6 years. He...